A human elastin-like polypeptide fused with human β-defensin 1 created a dual-function biomaterial that kills E. coli and strongly promotes cell adhesion in both 2D and 3D formats.
Dual-function biomaterialkills E. coli while strongly promoting cell adhesion in 2D and 3D formats, combining antimicrobial defense with tissue-healing support
What the researchers found
The HELP-hBD1 fusion biopolymer and its released active forms inhibited E. coli growth in redox environments. The fusion construct successfully produced the structurally complex human β-defensin 1, which is normally difficult to synthesize chemically due to its folding constraints.
Remarkably, 2D and 3D materials derived from the biopolymer showed strong cell adhesion-promoting activity, demonstrating dual functionality: antimicrobial protection and support for tissue growth. Engineered endoproteinase recognition sites allowed release of active hBD1 forms from the fusion carrier.
Why it matters
Biomaterials that simultaneously fight infection and promote tissue healing address a major clinical need. Surgical implants, wound dressings, and tissue engineering scaffolds are often compromised by bacterial colonization. This polypeptide-defensin fusion combines antimicrobial defense with cell-friendly properties in a biodegradable, biocompatible material — and uses a sustainable recombinant production method.
How the study worked
The researchers designed a gene encoding human elastin-like polypeptide fused with human β-defensin 1, incorporating specific endoproteinase cleavage sites. The construct was expressed recombinantly and purified. Antimicrobial activity was tested against E. coli. 2D and 3D materials were fabricated from the biopolymer and tested for cell adhesion and cytocompatibility.
What this study cannot tell us
Antimicrobial activity was demonstrated only against E. coli — testing against a broader range of pathogens, including gram-positive bacteria and fungi, would strengthen the case. The study did not include in vivo testing. The redox-dependent antimicrobial activity may limit the material's effectiveness in all tissue environments. Scale-up of recombinant production for clinical-grade materials was not addressed.
How to read the evidence
This is a preclinical biomaterials study demonstrating proof of concept for a novel fusion polypeptide. While the in vitro results are promising, in vivo validation is needed.
When this study was published
Published in 2024 in Journal of Materials Chemistry B, this represents recent progress in combining antimicrobial peptides with biomaterial engineering for regenerative medicine.
The bigger picture
This work combines peptide biology, materials science, and biotechnology. Using elastin-like polypeptides as carriers for difficult-to-produce antimicrobial peptides is an innovative production strategy that could be applied to other AMPs. The dual antimicrobial-adhesive functionality positions this material for applications in wound healing, orthopedic implants, and tissue engineering.
Questions still open
- Would the biomaterial prevent infection on surgical implants in animal models?
- Is the antimicrobial activity maintained long-term, or does it diminish as the material degrades?
- Could other antimicrobial peptides be similarly fused to the HELP carrier for broader-spectrum protection?
Common questions
What is an elastin-like polypeptide?
Why fuse a defensin with a biomaterial?
Read the original research
Materials derived from the human elastin-like polypeptide fusion with an antimicrobial peptide strongly promote cell adhesion.
Journal of materials chemistry. B, 12(36), 8966-8976
Citation
Colomina-Alfaro, Laura; Sist, Paola; D'Andrea, Paola; Urbani, Ranieri; Marchesan, Silvia; Stamboulis, Artemis; Bandiera, Antonella. (2024). Materials derived from the human elastin-like polypeptide fusion with an antimicrobial peptide strongly promote cell adhesion.. Journal of materials chemistry. B, 12(36), 8966-8976. https://doi.org/10.1039/d4tb00319e